Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
Clinical trial NCT06071962 · UNKNOWN
Trial details
- NCT number
- NCT06071962
- Sponsor
- Apurano Pharmaceuticals GmbH
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-02
- Primary completion
- 2024-09-30
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.